- Home
- EXEL vs EXP Comparison
EXEL vs EXP Comparison
Compare EXEL & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- EXP
- Stock Information
- Founded
- EXEL 1994
- EXP 1963
- Country
- EXEL United States
- EXP United States
- Employees
- EXEL N/A
- EXP N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- EXP Building Materials
- Sector
- EXEL Health Care
- EXP Industrials
- Exchange
- EXEL Nasdaq
- EXP Nasdaq
- Market Cap
- EXEL 9.4B
- EXP 7.6B
- IPO Year
- EXEL 2000
- EXP 1994
- Fundamental
- Price
- EXEL $37.42
- EXP $229.49
- Analyst Decision
- EXEL Buy
- EXP Buy
- Analyst Count
- EXEL 18
- EXP 11
- Target Price
- EXEL $37.59
- EXP $286.36
- AVG Volume (30 Days)
- EXEL 2.8M
- EXP 391.3K
- Earning Date
- EXEL 04-29-2025
- EXP 01-29-2025
- Dividend Yield
- EXEL N/A
- EXP 0.44%
- EPS Growth
- EXEL 170.77
- EXP N/A
- EPS
- EXEL 1.76
- EXP 13.93
- Revenue
- EXEL $2,168,701,000.00
- EXP $2,267,040,000.00
- Revenue This Year
- EXEL $5.45
- EXP $1.76
- Revenue Next Year
- EXEL $10.32
- EXP $5.39
- P/E Ratio
- EXEL $21.43
- EXP $16.42
- Revenue Growth
- EXEL 18.50
- EXP 0.64
- 52 Week Low
- EXEL $20.14
- EXP $205.44
- 52 Week High
- EXEL $40.02
- EXP $321.93
- Technical
- Relative Strength Index (RSI)
- EXEL 58.85
- EXP 51.84
- Support Level
- EXEL $36.68
- EXP $212.27
- Resistance Level
- EXEL $37.99
- EXP $228.18
- Average True Range (ATR)
- EXEL 1.09
- EXP 6.60
- MACD
- EXEL -0.11
- EXP 2.70
- Stochastic Oscillator
- EXEL 49.87
- EXP 92.90
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.